ProShares Ultra CRCL (CRCA)

NYSEARCA: CRCAProSharesTrading--Leveraged EquityETFUSD

18.22+1.49 (+8.91%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

CRCA chart

Key facts

Expense ratio: 0.95%
Assets (AUM): $98.56M
Dividend yield: 4.59%
Holdings: —
Inception: Aug 6, 2025
Issuer: ProShares
Index tracked: —
Category: Trading--Leveraged Equity
52-week range: 10.07 – 167.10
Volume / Avg: 564.20K / 942.38K
Beta: —
Previous close: 16.73

CRCA ETF today

The ProShares Ultra CRCL (CRCA) is an exchange-traded fund from ProShares in the Trading--Leveraged Equity category. It charges an expense ratio of 0.95%, or $95.00 per year on a $10,000 investment, and manages $98.6 million in assets. CRCA is down 54.9% year to date and has lost 87.8% over the past 12 months.

The fund's trailing dividend yield is 4.59% ($0.00 per share annually). CRCA launched on Aug 6, 2025.

Summary generated from market data by MetaCap's automated system. Methodology

CRCA performance

1 week

+7.18%

1 month

-22.73%

3 months

+30.24%

6 months

-46.90%

Year to date

-54.90%

1 year

-87.83%

CRCA price return, excluding dividends.

ETFs similar to CRCA

SPYState Street SPDR S&P 500 ETF Trust778.57 +0.60%VOOVanguard S&P 500 ETF715.59 +0.61%IVViShares Core S&P 500 ETF781.97 +0.60%RSPInvesco S&P 500 Equal Weight ETF213.04 +0.55%

CRCA ETF FAQ

What is the CRCA price today?

CRCA last traded at $18.22 as of Oct 9, 4:00 PM EDT, up 8.91% on the day.

What is CRCA's expense ratio?

CRCA has an expense ratio of 0.95%, which works out to about $95.00 per year for every $10,000 invested.

Does CRCA pay a dividend?

Yes. CRCA has a trailing dividend yield of 4.59% and pays quarterly distributions; the most recent was $0.126 per share with an ex-dividend date of Sep 23, 2026.

How big is CRCA?

CRCA has about $98.6 million in assets under management.